The prevalence of Huntington disease (HD) has increased over time; however, there is a lack of up‐to‐date evidence documenting the economic burden of HD by disease stage. This study provides… Click to show full abstract
The prevalence of Huntington disease (HD) has increased over time; however, there is a lack of up‐to‐date evidence documenting the economic burden of HD by disease stage. This study provides an estimate of the annual direct medical, nonmedical, and indirect costs associated with HD from participants in the Huntington's Disease Burden of Illness (HDBOI) study in five European countries and the USA.
               
Click one of the above tabs to view related content.